摘要
华蟾素注射液是我国自行研制的二类新药，具有调节免疫、抑制肿瘤细胞增殖、抗乙肝病毒的药理作用。在治疗中晚期肿瘤，慢性乙型肝炎，流行性出血热等疾病临床治疗上已经得到广泛应用。近年来在眼科多有应用，尤其在角膜炎，翼状胬肉等疾病取得进展。运用中西医结合的方法，探讨眼科新的治疗途径，发挥中医药的优势，是今后眼科临床治疗及研究的方向。
The cinobufotalin injection was independently developed by China ,this new second category drugs has pharmacological effects of regulation of the immune system ,inhibition of tumor cell proliferation and anti-hepatitis B virus .It Has been widely used to treat malignant tumor advanced stage , chronic hepatitis B ,epidemic hemorrhagic fever and clinical treatment of other diseases .In recent years ,there are many applications in ophthalmology .Much progresses has been made particularly in the diseases such as keratitis ,pterygium etc .This integrative treatments ,making use of the advantage of the Chinese Traditional medicine ,exploring ophthalmology new therapeutic approach ,will be the direction of ophthalmic clinical treatment and research in the future .
出处
《中医眼耳鼻喉杂志》
2013年第1期49-50,53,共3页
Journal of Chinese Ophthalmology and Otorhinolaryngology
关键词
华蟾素注射液
临床应用
眼科
Cinobufacini injection
Clinical application
Ophthalmology
